Nark Ted C 4
4 · Amneal Pharmaceuticals, Inc. · Filed Aug 28, 2019
Insider Transaction Report
Form 4
Nark Ted C
Director
Transactions
- Purchase
Class A Common Stock
2019-08-28$2.39/sh+50,000$119,500→ 56,107 total
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.38 per share to $2.44 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.